Calcaratarin D, A Labdane Diterpenoid, Attenuates Bleomycin-induced Pulmonary Fibrosis by Blocking WNT/beta-catenin Signaling Pathway

被引:0
|
作者
Liao, W. [1 ]
Wong, W. [1 ]
机构
[1] Natl Univ Hlth Syst, Pharmacol, Singapore, Singapore
基金
新加坡国家研究基金会;
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A2811
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ
    Qian Zeng
    Ting-ting Zhou
    Wen-jie Huang
    Xiao-ting Huang
    Lei Huang
    Xiao-hua Zhang
    Xiao-xue Sang
    Yu-yang Luo
    Yu-mei Tian
    Bin Wu
    Lin Liu
    Zi-qiang Luo
    Bin He
    Wei Liu
    Si-yuan Tang
    Scientific Reports, 13
  • [32] Paricalcitol inhibits the Wnt/beta-catenin signaling pathway and ameliorates experimentally induced arthritis
    Yolbas, Servet
    Yildirim, Ahmet
    Tektemur, Ahmet
    Celik, Zulfinaz Betul
    Onalan Etem, Ebru
    Ozercan, Ibrahim Hanifi
    Akin, Mehmet Mustafa
    Koca, Suleyman Serdar
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (05) : 1080 - 1086
  • [33] Neferine, a bisbenzylisoquinline alkaloid attenuates bleomycin-induced pulmonary fibrosis
    Zhao, Libo
    Wang, Xiaomin
    Chang, Qing
    Xu, Junying
    Huang, Ying
    Guo, Qiuyun
    Zhang, Shaohui
    Wang, Wenquan
    Chen, Xiujuan
    Wang, Jialing
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 627 (1-3) : 304 - 312
  • [34] Hyperoside Attenuates Bleomycin-Induced Pulmonary Fibrosis Development in Mice
    Huang, Jizhen
    Tong, Xiang
    Zhang, Li
    Zhang, Yuan
    Wang, Lei
    Wang, Dongguang
    Zhang, Shijie
    Fan, Hong
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [35] Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPAR?
    Zeng, Qian
    Zhou, Ting-ting
    Huang, Wen-jie
    Huang, Xiao-ting
    Huang, Lei
    Zhang, Xiao-hua
    Sang, Xiao-xue
    Luo, Yu-yang
    Tian, Yu-mei
    Wu, Bin
    Liu, Lin
    Luo, Zi-qiang
    He, Bin
    Liu, Wei
    Tang, Si-yuan
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [36] IL-12 attenuates bleomycin-induced pulmonary fibrosis
    Keane, MP
    Belperio, JA
    Burdick, MD
    Strieter, RM
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2001, 281 (01) : L92 - L97
  • [37] Hydroxysafflor Yellow A Attenuates Bleomycin-induced Pulmonary Fibrosis in Mice
    Jin, Ming
    Wu, Yan
    Wang, Lin
    Zang, Baoxia
    Tan, Li
    PHYTOTHERAPY RESEARCH, 2016, 30 (04) : 577 - 587
  • [38] Treatment with α-galactosylceramide attenuates the development of bleomycin-induced pulmonary fibrosis
    Kimura, T
    Ishii, Y
    Morishima, Y
    Shibuya, A
    Shibuya, K
    Taniguchi, M
    Mochizuki, M
    Hegab, AE
    Sakamoto, T
    Nomura, A
    Sekizawa, K
    JOURNAL OF IMMUNOLOGY, 2004, 172 (09): : 5782 - 5789
  • [39] Panax notoginseng Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice
    Tsai, Kuen-Daw
    Yang, Shu-Mei
    Lee, Jen-Chih
    Wong, Ho-Yiu
    Shih, Chuen-Ming
    Lin, Ting-Hui
    Tseng, Min-Jen
    Chen, Wei
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2011, 2011 : 1 - 7
  • [40] Extracellular Matrix Powder Attenuates Bleomycin-Induced Pulmonary Fibrosis
    Manni, M. L.
    Tobolewski, J. M.
    Gilbert, T. W.
    Oury, T. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179